FDA Inspection 1205935 — Columbus Center for Reproductive Endocrinology & Infertility, LLC

Columbus Center for Reproductive Endocrinology & Infertility, LLC — FEI 3005144073

The FDA completed an inspection of Columbus Center for Reproductive Endocrinology & Infertility, LLC on April 25, 2023 in Columbus, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 25, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Columbus, GA (United States)